Nivolumab in advanced hepatocellular carcinoma (HCC) and Child Pugh B (CPB) cirrhosis: Safety and clinical outcomes in a retrospective case series
Kambhampati, Swetha, Bauer, Kelly, Hwang, Jimmy, Bocobo, Andrea Grace, Gordan, John Dozier, Kelley, Robin Kate
Published in Journal of clinical oncology (01.02.2018)
Published in Journal of clinical oncology (01.02.2018)
Get full text
Journal Article
Computational extraction and analysis of de-identified medical records to characterize hyperammonemia in patients with fibrolamellar carcinoma (FLC)
Zack, Travis, Maisel, Samantha, O'Neill, Allison Frances, La Quaglia, Michael P., Herman, Michael, Knox, Jennifer J., Yaqubie, Amin, Venook, Alan P., Mayer, Robert J., Gordan, John Dozier, Abou-Alfa, Ghassan K.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Evaluation of neratinib (N), pembrolizumab (P), everolimus (E), and nivolumab (V) in patients (pts) with fibrolamellar carcinoma (FLC)
Abou-Alfa, Ghassan K., Meyer, Tim, Zhang, Jie, Sherrin, Scott, Yaqubie, Amin, Clemens O’Neill, Alison, Xu, Feng, Eli, Lisa D, Harding, James J., O'Reilly, Eileen Mary, Lalani, Alshad S., Bryce, Richard, Gordan, John Dozier
Published in Journal of clinical oncology (20.01.2021)
Published in Journal of clinical oncology (20.01.2021)
Get full text
Journal Article
Changes in alpha-fetoprotein (AFP) and systemic therapy outcomes in advanced hepatocellular carcinoma (HCC): A multicenter retrospective analysis
Bocobo, Andrea Grace, Bracci, Paige M., Parks, Anna, Hannan, Lindsay Marie, Bauer, Kelly, Goyal, Lipika, Gordan, John Dozier, Venook, Alan P., Harris, William Proctor, Kelley, Robin Kate
Published in Journal of clinical oncology (01.02.2019)
Published in Journal of clinical oncology (01.02.2019)
Get full text
Journal Article
A novel preclinical model of cholangiocarcinoma based on human aberrant FBXW7 expression
Wang, Jingxiao, Wang, Haichuan, Peters, Michele, Ding, Ning, Ribback, Silvia, Utpatel, Kirsten, Evert, Matthias, Cigliano, Antonio, Dombrowski, Frank, Song, Xinhua, Cossu, Antonio, Xu, Meng, Che, Li, Gordan, John Dozier, Calvisi, Diego, Chen, Xin
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Phase II multicenter pilot study of safety, efficacy, and immune cell profiling in advanced hepatocellular carcinoma (HCC) on combination of sorafenib (SOR) plus nivolumab (NIVO)
Keenan, Bridget, Griffith, Madeline J, Bauer, Kelly, Bracci, Paige M., Behr, Spencer, Umetsu, Sarah E, Gordan, John Dozier, Ngo, Zoe, Iqbal, Syma, Hanna, Diana L., Venook, Alan P., El-Khoueiry, Anthony B., Fong, Lawrence, Kelley, Robin Kate
Published in Journal of clinical oncology (01.02.2019)
Published in Journal of clinical oncology (01.02.2019)
Get full text
Journal Article
Phase II trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC)
Kelley, Robin Kate, Mitchell, Emily, Behr, Spencer, Hwang, Jimmy, Keenan, Bridget, Cheung, Alexander, Gordan, John Dozier, Ko, Andrew H., Cinar, Pelin, Atreya, Chloe Evelyn, Van Loon, Katherine, Weber, Thomas, Ngo, Zoe, Quandt, Zoe E., Liu, Chienying, Venook, Alan P., Fong, Lawrence
Published in Journal of clinical oncology (01.02.2018)
Published in Journal of clinical oncology (01.02.2018)
Get full text
Journal Article
Next-generation sequencing (NGS) in an advanced hepatocellular carcinoma (HCC) cohort: Analyses of TP53 and CTNNB1
Kelley, Robin Kate, Gordan, John Dozier, Evason, Kimberley, Bracci, Paige M., Joseph, Nancy M., Bocobo, Andrea Grace, Rosenthal, Blake K., Nimeiri, Halla Sayed, Venook, Alan P.
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article
Phase 2 trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC): Clinical outcomes and biomarker analyses
Kelley, Robin Kate, Mitchell, Emily, Behr, Spencer, Hwang, Jimmy, Keenan, Bridget, Umetsu, Sarah E, Gordan, John Dozier, Ko, Andrew H., Cinar, Pelin, Atreya, Chloe Evelyn, Van Loon, Katherine, Weber, Thomas, Ngo, Zoe, Quandt, Zoe E., Liu, Chienying, Venook, Alan P., Fong, Lawrence
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Detection of circulating tumor cells (CTC) using a non-EpCAM-based, high-definition, single-cell assay in advanced hepatocellular carcinoma (HCC) for patients enrolled on phase I and II trials of sorafenib plus temsirolimus
Kelley, Robin Kate, Rodriguez Lee, Mariam, Hwang, Jimmy, Gordan, John Dozier, Nimeiri, Halla Sayed, Bocobo, Andrea Grace, Kircher, Sheetal Mehta, Kanakamedala, Advaita, Mulcahy, Mary Frances, Benson, Al Bowen, Kuhn, Peter, Venook, Alan P.
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Next-generation sequencing (NGS) in an advanced hepatocellular carcinoma (HCC) cohort: Analysis of common mutations, clinical covariates, and overall survival (OS)
Kelley, Robin Kate, Bracci, Paige M., Gordan, John Dozier, Evason, Kimberley, Joseph, Nancy M., Bocobo, Andrea Grace, Rosenthal, Blake K., Stoppler, Hubert J., Nimeiri, Halla Sayed, Venook, Alan P.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Phase II trial of temsirolimus (TEM) plus sorafenib (SOR) in hepatocellular carcinoma (HCC)
Kelley, Robin Kate, Nimeiri, Halla Sayed, Gordan, John Dozier, Hwang, Jimmy, McWhirter, Ryan M., Kanakamedala, Advaita, Atreya, Chloe Evelyn, Kulik, Laura, Kircher, Sheetal, Mulcahy, Mary Frances, Benson, Al Bowen, Venook, Alan P.
Published in Journal of clinical oncology (20.01.2015)
Published in Journal of clinical oncology (20.01.2015)
Get full text
Journal Article
Randomized phase II study of everolimus (E), leuprolide + letrozole (LL), and E + LL (ELL) in patients (pts) with unresectable fibrolamellar carcinoma (FLC)
Abou-Alfa, Ghassan K., Mayer, Robert J., Cosgrove, David, Capanu, Marinela, Choti, Michael A., Atreya, Chloe Evelyn, Ang, Celina, Kelley, Robin Kate, Do, Richard Kinh Gian, Gordan, John Dozier, Zhu, Andrew X., Ly, Michele, Nolan, Patrick, Lubin, Lakeisha, Harding, James J., Saltz, Leonard, Venook, Alan P.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article